Cation-π interactions have been demonstrated to play a major role in agonist-binding in Cys-loop receptors. However, neither the aromatic amino acid contributing to this interaction nor its location are conserved among Cys-loop receptors. Similarly, it is not clear how many different agonists of a given receptor form a cation-π interaction, or, if they do, whether it is with the same aromatic amino acid as the major physiological agonist. We previously demonstrated that Phe159 in the glycine receptor (GlyR) α1 subunit forms a strong cation-π interaction with the principal agonist, glycine. In this study we investigated whether the lower efficacy agonists of the human GlyR, β-alanine and taurine, also form cation-π interactions with Phe159. By incorporating a series of unnatural amino acids we found cation-π interactions between Phe159 and the amino groups of β-alanine and taurine.
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Introduction
Glycine receptors (GlyRs) are ligand-gated chloride channels expressed mainly at inhibitory synapses in brain stem and spinal cord (Lynch, 2004) . In these tissues GlyRs contribute to the generation of motor rhythm, coordination of reflex circuits, and the processing of sensory signals (Harvey et al., 2004; Legendre, 2001) . Along with GABA A receptors (GABA A Rs), 5-hydroxytryptamine 3 receptors (5-HT 3 Rs) and nicotinic acetylcholine receptors (nAChRs), GlyRs belong to the Cys-loop receptor family (Le Novere and Changeux, 2001 ). All Cys-loop members are comprised of five subunits that are pseudosymmetrically arranged around a central ion-conducting pore. Individual subunits consist of a large N-terminal ligand-binding domain (LBD) and four transmembrane helices that are connected by loops of varying size (Miyazawa et al., 2003; Unwin, 1995) . Structural studies on acetylcholine binding proteins (AChBPs) (Brejc et al., 2001 ) and prokaryotic Cys-loop receptor homologues (Bocquet et al., 2009; Hilf and Dutzler, 2008; Hilf and Dutzler, 2009 ) have confirmed the location of the agonist binding site at the interface of adjacent subunits. Three loops from one subunit (A-C) and three β strands from the adjacent subunit (D-F) create the binding pocket. Like all Cys-loop receptors, the GlyR binding site is lined with aromatic residues, and we have previously
shown that a cation-π interaction between the positively charged amine of glycine and Phe159 in loop B makes a substantial contribution to agonist binding (Pless et al., 2008) .
Similarly, other studies have shown that aromatic side chains form cation-π interactions with the principal agonists of other Cys-loop receptors, such as nACh, 5-HT 3 , MOD-1 (modulation of locomotion defective 1), and GABA A receptors (Beene et al., 2002; Dougherty, 2008; Lummis et al., 2005; Mu et al., 2003; Padgett et al., 2007; Zhong et al., 1998) . However, the nature and location of the aromatic residue that interacts with the cation is not conserved among Cys-loop receptors or among different agonists for a given This article has not been copyedited and formatted. The final version may differ from this version. (Beene et al., 2002; Dougherty, 2008; Mu et al., 2003; Xiu et al., 2009) . Recent kinetic studies on the mechanism of partial agonism (Lape et al., 2008) have sparked a renewed interest in the question how partial agonists differ in their mechanism of action.
Although a number of studies have established how glycine binds to the GlyR (Grudzinska et al., 2005; Pless et al., 2008) , little is known about the binding mode of other GlyR agonists such as β -alanine and taurine, which are both endogenous amino acid agonists of the GlyR (Lewis et al., 2003; Schmieden et al., 1992) . β -Alanine and taurine are structurally similar to glycine (Fig. 1A ) and both agonists compete for the same binding site (Schmieden and Betz, 1995; Schmieden et al., 1992) According to a single channel kinetic analysis, dissociation rates for β-alanine and taurine are increased 2.5 fold and 4 fold, respectively (compared to glycine), and efficacy 2 fold and 5 fold (Lewis et al., 2003) . To explore the molecular mechanism(s) involved in these differences we used the nonsense suppression methodology (Beene et al., 2003; Dougherty, 2000) to incorporate unnatural amino acids into the GlyR binding site to determine if β -alanine and taurine, like glycine, form a cation-π interaction with a phenylalanine residue at position 159.
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Materials and Methods
Mutagenesis and Preparation of mRNA and Oocytes. For optimal expression in oocytes, the human GlyR α 1 subunit cDNA was subcloned into the pGEMHE vector. The QuickChange mutagenesis kit (Stratagene, La Jolla, CA) was used for site-directed mutagenesis.
Successful incorporation of mutations was confirmed by automated sequencing. Capped cRNA for oocyte injection was generated using the mMessage mMachine kit (Ambion, Austin, TX). Xenopus laevis (Nasco, WI). Oocytes were prepared as previously described (Pless et al., 2007) , and injected with cRNA alone or cRNA plus tRNA (see below). After injection, oocytes were incubated for 18 to 36 h at 18°C.
Synthesis of tRNA and dCA amino acids. The procedure used here has been previously described (Beene et al., 2004) . In short, unnatural amino acids (as shown in Figure 1 ) were chemically synthesized as NVOC (nitroveratryloxycarbonyl)-protected cyanomethyl esters and coupled to the dinucleotide dCA. The resulting product was subsequently ligated enymatically to a 74-mer THG73 tRNA CUA as described (Nowak et al., 1998) . The aminoacyl tRNA was deprotected by photolysis (Kearney et al., 1996) directly prior to coinjection with the mRNA. Typically, 10 to 15 ng of mRNA were co-injected with 20 to 30 ng of tRNA-amino acid in a total volume of 50 nl mRNA containing the TAG stop codons was injected alone or together with tRNA-dCA (with no amino acid attached) in control experiments. Under these conditions we never observed measurable currents, even at high (5 mM) concentrations of agonist (n = 6). This result confirmed that the constructs containing the TAG stop codon generated truncated and hence nonfunctional receptors. It also suggests that no endogenous amino acids from the oocyte are incorporated at these sites and, finally, that the tRNAs are not reacylated with naturally occurring amino acids by endogenous synthetases.
This article has not been copyedited and formatted. The final version may differ from this version. Modeling This was performed as described previously (Reeves et al., 2003; Thompson et al., 2005) . Three-dimensional models of the extracellular region of the glycine receptor were built using MODELLER 6, version 2 (Sali and Blundell, 1993) based on the crystal structure of AChBP in the agonist bound state (carbomylcholine, PDB ID; 1uv6). The model was energy minimized in SYBYL version 6.8 using the AMBER force field by moving side chains alone (Weiner et al., 1984) . Models and predicted hydrogen bonds were viewed using ViewerLite version 5.0. Docking was performed using GOLD 3.0 (The Cambridge Crystallographic Data Centre, Cambridge, UK) as previously described (Thompson et al., 2007; Thompson and Lummis, 2007) with the ligands constrained to dock within 4.5Å of Arg65, as a previous study has convincingly demonstrated that Arg65 is a common anchor point for the carboxyl termini of different agonists (e.g. glycine and taurine) (Grudzinska et al., 2005) .
Results
Locating the residues of interest using conventional mutagenesis. In this study, we chose to focus on Phe63, Phe159 and Phe207. Mutations at these sites markedly affect receptor function, and aligning residues in other receptors form cation-π interactions in previous studies (Grudzinska et al., 2005; Rajendra et al., 1995b; Pless et al., 2008) . Phe63Ala substitution caused increases in EC 50 s of 760, 280 and 360 fold for glycine, β-alanine and taurine, while Phe63Tyr substitution had smaller effects on glycine and β-alanine responses (17 and 57 fold increases in EC 50 respectively), but no responses were detected with taurine, perhaps indicating size here is critical for taurine binding/activation (Table 1) .
Phe159Tyr substitution decreased EC 50 s for all three agonists as previously reported (Schmieden et al., 1993) while Phe159Ala substitution caused large increases (70-260 fold) (Table 1) .
Phe207Ala substitution eliminated all agonist responses. Phe207Tyr had no significant effect on EC 50 s. This mutation did, however, decrease R max (Table 1) .
Other aromatic residues near the GlyR binding pocket, such as Phe99, Phe100, and Tyr202 could also potentially contribute to ligand binding, but previous studies using conventional mutagenesis have ruled out cation-π interactions at these sites (see Discussion for details). Table 2 ). These results strongly suggest a cation-π interaction between β -alanine and Phe159. The data include not only fluorinated analogues, but also a Phe derivative with a cyano group in the 4 position. 4-CN-Phe is slightly larger in size than the fluorinated Phe derivatives but is well-tolerated in Cys-loop receptor binding sites (Padgett et al., 2007; Pless et al., 2008) . This substitution yielded a β -alanine EC 50 between those for 3,4-F 2 -Phe and 3,4,5-F 3 -Phe, consistent with the cation-π binding ability of 4-CN-Phe.
Characterisation of the
A plot of the data reveal a strong linear correlation between the relative log EC 50 value (scaled to WT) and the cation-π binding ability of the incorporated Phe derivative (Fig.   3A ), consistent with a cation-π interaction between β -alanine and Phe159 (Mecozzi et al., 1996 ; Zhong et al., 1998) . The slope of this linear fit was significantly lower than that of glycine ( Fig. 3C ).
Comparing glycine-induced currents ( 10 these data indicate a cation-π interaction between taurine and Phe159 (Fig. 3B ). The slope of the linear fit for taurine is less than that for β-alanine (Fig. 3C ), suggesting a weaker interaction here.
Taurine effects at Tyr161 mutant receptors
Previous data suggest that Tyr161 may participate in agonist binding at the GlyR: its substitution with Phe, combined with a Phe159Tyr mutation, resulted in a receptor that was ~100 fold more highly sensitive to β -alanine and ~30 fold more sensitive to taurine (Schmieden et al., 1993) . The β -alanine effect has been shown to be indirect (De Saint Jan et al., 2001 ), but the increase in taurine EC 50 (~5 fold) with 4-F-Phe at this position suggesting a possible cation-π interaction. Substitution with 4-CN-Phe, however, resulted in a taurine EC 50 similar to WT receptors, indicating there is no cation-π interaction here (Table 3) .
Characterisation of the Phe207TAG construct. 4-F-Phe substitution at position 207 did not change the β -alanine EC 50 compared to WT ( Table 2) . Incorporation of 3,4-F 2 -Phe and 3,4,5-F 3 -Phe resulted in large increases in the β -alanine EC 50 (60 and 90-fold, respectively), although substitution with 4-CN-Phe only produced only a 9-fold increase in EC 50 ; these data are inconsistent with a cation-π interaction. The pattern was broadly similar for taurine, with no change in the EC 50 with 4-F-Phe, but some increases when 3,4-F 2 -Phe and 3,4,5-F 3 -Phe were incorporated (11 and 7-fold respectively; Table 3 ). These data also do not support a cation-π interaction at position 207.
In comparison to the maximum currents observed with Phe207 mutants for glycine, (similar to wild type) R max values were much reduced when these mutants were activated by β-alanine or taurine (Tables 2 and 3 ). Changes in R max values may indicate an effect on receptor gating, so Phe207 may play a different role in gating for these partial agonists than for the full agonist glycine.
This article has not been copyedited and formatted. The final version may differ from this version. alanine into the same model, and the data show that it is located in a broadly similar orientation to glycine, but the amino group is further from the centre of Phe159 than the amino group of glycine ( Fig. 4D/E) .
Locating taurine in the binding pocket. We also docked taurine into the ligand binding pocket, and the results reveal that its amino group, like that of β-alanine, is further from Phe159 than the amino group of glycine. However, the major difference compared to glycine is the location of the sulphonate group, which is close to Phe63 (Fig. 4F/G ). This location is supported by the mutagenesis data, which suggest taurine is more sensitive than glycine and β-alanine to changes in this residue (Tables 1 & 3) .
Discussion
In this study, we demonstrate that the GlyR partial agonists β-alanine and taurine can form cation-π interactions with Phe159 in the binding pocket of the glycine receptor. For both ligands there is a clear correlation between the EC 50 and the cation-π binding ability of phenylalanine derivatives incorporated at position 159 in the GlyR (Fig. 3) reported (Mu et al., 2003; Padgett et al., 2007 ).
An intriguing aspect of our new data is the fact that the slopes of the fluorination plots for β-alanine and taurine are significantly reduced compared to that for glycine (Fig. 3C ). This suggests that the relative strength of the cation-π interactions is glycine > β-alanine > taurine, as weakening of the cation-π interaction by successive fluorination has the most dramatic effect on activation by glycine, then β-alanine and finally taurine. The slope for glycine (Pless et al., 2008) resembles that of other agonists containing a primary amine, This article has not been copyedited and formatted. The final version may differ from this version. (Pless et al., 2008) , while the slopes for β -alanine and taurine are more similar to that of the quaternary ammonium ion of acetylcholine (β-alanine = -0.13; taurine = -0.09; acetylcholine = -0.10) (Zhong et al., 1998) . It has been previously suggested that the less focussed charge of the quaternary ammonium ion of acetylcholine leads to a weaker cation-π interaction compared to agonists with a primary amine, such as glycine, serotonin and GABA (Beene et al., 2002; Pless et al., 2008) . Here, however, we show that agonists with primary amines (β-alanine and taurine) can also form cation-π interactions that are similar to those formed by agonists with a quaternary ammonium. This seems to suggest that it is not only the nature of the cationic moiety but also the exact orientation that determines the strength of a cation-π interaction at a given site. Such an idea is consistent with a computational study which demonstrated that the exact orientation of the aromatic residue and the cation are crucial for a strong cation-π interaction (Gallivan and Dougherty, 1999).
To further explore this hypothesis we examined the possible locations of the agonists in a model of the GlyR binding site. The only structural difference between glycine and β -alanine is the slightly elongated carbonyl backbone of β -alanine (Fig. 1A) . Docking studies locate the amino group of β -alanine further from the centre of the aromatic ring of Phe159, which would result in a weaker cation-π interaction (Fig. 4) .
Like β -alanine, taurine also has an elongated carbonyl backbone, and a sulphonate group in place of the carboxyl group (Fig. 1A) . Ligand docking shows that this molecule is also oriented with the amino group further displaced from Phe159 than it is for glycine, and it is in a different orientation to β -alanine, providing an explanation for the weaker cation-π interaction. It is however possible the model is not quite accurate for partial agonists, around the GlyR binding site (taurine < β-alanine < glycine), an idea that is also supported by a recent study using fluorescent reporter groups (Pless and Lynch, 2009 ).
These different conformational changes could possibly be the cause of the different magnitudes of the responses produced by these different agonists, i.e. their efficacy.
Intrinsic efficacy is related to agonist concentration, agonist affinity, and receptor number (Furchgott, 1966) , but is also dependent on other factors including the receptor state (e.g.
open, closed, desensitised) and the kinetics of the interactions between these states (Colquhoun and Hawkes, 1987) . In addition there are contributions from more 'external' factors, such as the expression system or brain region; taurine, for example, has different efficacies in oocytes and HEK cells, and also in brain and spinal cord neurones (Farroni and McCool, 2004; Killcross et al. 1997 ). Therefore it is not surprising that a quantitative understanding of the link between the receptor-ligand interactions and efficacy is still in its infancy. We are tempted to speculate that the different strengths of the different cation-π interactions with the different agonists are related to their different efficacies. A lower efficacy could be the result of reduced loop C closure, due to a decrease in cation-π binding energy, which could result in less efficient receptor activation. This may be reflected in -or caused by -the decrease in desensitization rates that we observed, which indicates a change This article has not been copyedited and formatted. The final version may differ from this version. In principle, aromatic amino acids other than Phe159 could also contribute to a cation-π interaction in the GlyR binding site. Phe99, Phe100, Tyr161 and Tyr202 are located close to the binding site, but previous studies have suggested that they are unlikely to contribute to a cation-π interaction. Substituting Phe99 or Phe100 with a small and non-aromatic amino acid, alanine, resulted in only a minor shift in the EC 50 s (Vafa et al., 1999) . A pioneering study suggested that Tyr161 was important for β -alanine binding (Schmieden et al., 1993) but more recent work convincingly demonstrated that this residue has only indirectly effects (De Saint Jan et al., 2001 ). The present study also indicates that there is no cation-π interaction between this residue and taurine. Finally, two studies have demonstrated that it is the hydroxyl group of Tyr202 and not its aromatic character that is crucial for agonist binding (Grudzinska et al., 2005; Rajendra et al., 1995a) .
It is also conceivable that the cation originates from a positively charged amino acid near the binding site, rather than the amino group of the ligand: Arg65, Arg131, Lys200 and Lys206 are all in close physical proximity to the binding site. However, neutralising Arg131, Lys200 or Lys206 results in only minor shifts in agonist EC 50 s (Vandenberg et al., 1992; Yang et al., 2007) , while Arg65 interacts with the negatively charged head group of both full and partial agonists (Grudzinska et al., 2005) . We thus conclude that it is the amino groups of β -alanine and taurine that form cation-π interactions with Phe159.
GlyRs are emerging as pharmacological targets, and thus the exact binding mechanism of full agonists, partial agonists and even antagonists in GlyRs is of particular interest (Laube This article has not been copyedited and formatted. The final version may differ from this version. Table 2 and 3) normalised to the WT log EC 50 was used to generate a plot of the GlyR 
